Thinking about trading options or stock in NVIDIA, Trump Media & Technology, Microsoft, Enterprise Products Partners, or Pfizer?
Thinking about trading options or stock in NVIDIA, Trump Media & Technology, Microsoft, Enterprise Products Partners, or Pfizer?
PR Newswire
NEW YORK, April 1, 2024
NEW YORK, April 1, 2024 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for NVDA, DJT, MSFT, EPD, and PFE.
Click a link below then choose between in-depth options trade idea report or a stock score report.
Options Report – Ideal trade ideas on up to seven different options trading strategies. The report shows all vital aspects of each option trade idea for each stock.
Stock Report - Measures a stock's suitability for investment with a proprietary scoring system combining short and long-term technical factors with Wall Street's opinion including a 12-month price forecast.
- NVDA: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=NVDA&prnumber=202404013
- DJT: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=DJT&prnumber=202404013
- MSFT: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=MSFT&prnumber=202404013
- EPD: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=EPD&prnumber=202404013
- PFE: https://www.investorsobserver.com/lp/pr-options-lp-2/?stocksymbol=PFE&prnumber=202404013
(Note: You may have to copy this link into your browser then press the [ENTER] key.)
InvestorsObserver provides patented technology to some of the biggest names on Wall Street and creates world-class investing tools for the self-directed investor on Main Street. We have a wide range of tools to help investors make smarter decisions when investing in stocks or options.
View original content to download multimedia:https://www.prnewswire.com/news-releases/thinking-about-trading-options-or-stock-in-nvidia-trump-media--technology-microsoft-enterprise-products-partners-or-pfizer-302104457.html
SOURCE InvestorsObserver
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise